[1]
2024. Hereditary angioedema type 1, limitations for prophylactic therapy with Lanadelumab: Regarding a case. Revista Alergia México. 71, 4 (Dec. 2024), 264–267. DOI:https://doi.org/10.29262/ram.v71i4.1323.